Matt Vesely MD, PhD FAAD

Assistant Professor of Dermatology @yalederm. Immunologist, physician-scientist. Proud dad @yalemed @yaleIBIO #autoimmunity #cancerimmunology #cutaneouslupus

[Matt Vesely MD, PhD FAAD @mdvesely]

🚀 Honored to be named a 2025 @the_asci Young Physician-Scientist Awardee! Grateful for the opportunity to advance research on immune checkpoints in autoimmune skin diseases & cancer at @YaleDerm & @YaleMed.

Excited to keep pushing the boundaries of translational medicine! 🔬✨

🔗 Learn more: ASCI YPSA 2025 Awardees

#ASCI #YPSA2025 #PhysicianScientist #Immunology #Dermatology #medicalresearch

[Yale Dermatology @yalederm]

March 8 presenters at #AAD2025:
William Damsky, MD, PhD; Bruce Strober, MD, PhD; Mona Shahriari; Jeffrey Cohen, MD; Mary Tomayko, MD, PhD; Keith Choate, MD, PhD; Matthew Vesely, MD, PhD; Noah Hornick, MD, PhD (alumnus); Alicia Little, MD, PhD
@AADmember

[Matt Vesely MD, PhD FAAD @mdvesely]

🚀ICYMI - current issue of @jidinnovations!

We provide a practical guide for using GeoMx Digital Spatial Profiler to map spatial transcriptomics in inflammatory skin diseases, unlocking new insights into tissue-specific inflammation & potential targets for therapy.

🔗 Read more: https://t.co/nIMUAWFdqw

#Dermatology #SpatialTranscriptomics #Inflammation #GeoMx #MedicalInnovation #SkinResearch

[Matt Vesely MD, PhD FAAD @mdvesely]

🚀 A New Frontier in Medicine! 🚀

Our Perspective @theJIDJournal explores how immune checkpoint agonists can reduce inflammation & restore immune homeostasis in atopic dermatitis, cutaneous lupus, & psoriasis.

Targeting immune resolution could transform treatment for inflammatory skin diseases!

Proud to collaborate with @PaulLizzul, @PaulKlekotka, @NicoleJoller, @AdamRaff. @AdvancingDerm

🔗 Read more: https://t.co/5mUNAYFQEi

#Immunology #Dermatology #Inflammation #ImmuneCheckpoints #MedicalInnovation

Thanks to @TeamSciStories for help with figure

[Matt Vesely MD, PhD FAAD @mdvesely]

Excited to speak at #AAD2025! Join me for "U046 - Knowing Lichenoid Dermatoses: Common Pathways & Treatments" on March 9 at 4:30 PM with @NoahHornickMD, & @AliciaLittleMD

We’ll dive into immunopathogenesis, clinical burden, & emerging therapies for lichen planus, lichen sclerosus, & immune checkpoint-induced lichenoid dermatoses.

Don’t miss it! 🔬✨

🔗 Learn more: https://t.co/R9EUckIqm6

#Dermatology #Immunology #MedicalEducation #AAD2025

[Matt Vesely MD, PhD FAAD @mdvesely]

Honored to be recognized as a Castle Connolly Top Doctor! Grateful to be part of @YaleDerm & @YaleMed, where I focus on autoimmune skin diseases, immunology, & skin cancer research.

Big thanks to my colleagues, mentors, and patients who inspire this work every day!

🔗 Learn more: https://t.co/yay0N0aIJb

#TopDoctor #CastleConnolly #Dermatology #Immunology #medicalresearch

[Matt Vesely MD, PhD FAAD @mdvesely]

🚨 New Target for cSCC Immunotherapy! 🚨

Immune checkpoint VISTA, linked to strong T cell activation in cutaneous SCC @theJIDJournal

#CancerResearch #Immunotherapy #VISTA #cSCC #immunecheckpoint #Oncology #skincancer #dermatology @YaleCancer @yalederm

https://t.co/z48CnuB3Co

[ASCI @the_asci]

The ASCI is proud to announce our 2025 Early-Career Awardees! Click here for the complete list of awardees:

YPSA: https://t.co/8JNkOWcdq5

E-Gen: https://t.co/oga7coPcTM

Congratulations to our awardees and to the institutions they represent!

[Journal of Clinical Investigation @jclinicalinvest]

Type 2 immunity to the rescue: enhancing anti-tumor immunity for skin cancer prevention: https://t.co/MVUV99TuZ8

@mdvesely & Sean R Christensen @YaleMed comment on Oka et al. (https://t.co/FONeeOk3kh)

[Matt Vesely MD, PhD FAAD @mdvesely]

Check out our new article on digital spatial profiling in inflammatory skin diseases.

[JID Innovations @jidinnovations]

An incredibly powerful tool to study skin disease: digital spacial profiling https://t.co/lBHZl2Rqnr #dermtwitter #medderm #dermtech

[JID Innovations @jidinnovations]

An incredibly powerful tool to study skin disease: digital spacial profiling https://t.co/lBHZl2Rqnr #dermtwitter #medderm #dermtech

[Matt Vesely MD, PhD FAAD @mdvesely]

***New Session*** at #AAD2024 on lichenoid dermaotses including lichen planus and lichen planopilaris with Dr. Jeff Cohen @yalederm and Dr. @CrystalAguhMD @HopkinsMedicine.

U023: Friday March 8 at 4:30 pm

[Matt Vesely MD, PhD FAAD @mdvesely]

Virtual Seminar on cutting-edge advances of immune inhibitory receptor VISTA as a target for #cancerimmunotherapy

March 27, 2024

Register:
https://t.co/j1JiXdyF4f

[Dermatology Advances @AdvancingDerm]

Last chance! Don't forget to join us for a FREE webinar, Putting the Brakes on Autoimmunity: Checkpoint Agonists in Dermatology, tomorrow, November 1, from 11 AM - 1 PM ET!

Register here: https://t.co/rNJ46XZcbF.
#AdvancingDerm #derminnovation #dermatology #webinar

[Dermatology Advances @AdvancingDerm]

Register for our free webinar on November 1st, from 11 AM - 1 PM ET featuring guest speakers:

Lieping Chen, MD, PhD
Nicole Joller, PhD
Paul Klekotka, MD, PhD, FAAD
Paul F Lizzul, MD, PhD
Adam Raff, MD, PhD, FAAD
Matthew Vesely MD, PhD

https://t.co/rNJ46XZcbF

#AdvancingDerm

[Matt Vesely MD, PhD FAAD @mdvesely]

There is still time to register for the @AdvancingDerm Webinar on Immune Checkpoint Agonist to treat #autoimmunity in #dermatology.

Wednesday November 1, 11 am - 1 pm EST

https://t.co/wEJsDLDnu1

[Matt Vesely MD, PhD FAAD @mdvesely]

Today is #WorldPsoriasisDay. Additional research is needed to advance therapies for people living with #Psoriasis and #PsoriaticArthritis #PsoriaticDisease.

Here is a multiplex image of #psoriasis using #MIBI @IonpathOfficial. Please support @NPF @IpcPs @PsoriasisIFPA